Nutrien (NYSE:NTR) Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS

Nutrien (NYSE:NTRGet Free Report) announced its earnings results on Wednesday. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.09), Zacks reports. Nutrien had a return on equity of 6.99% and a net margin of 2.79%.

Nutrien Stock Performance

Shares of NYSE NTR traded up $0.69 during mid-day trading on Wednesday, reaching $52.35. 2,798,533 shares of the company were exchanged, compared to its average volume of 2,288,583. The company’s 50-day simple moving average is $49.13 and its 200-day simple moving average is $48.13. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $25.71 billion, a P/E ratio of 35.13, a P/E/G ratio of 1.14 and a beta of 0.81. Nutrien has a twelve month low of $43.69 and a twelve month high of $60.87.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Oppenheimer assumed coverage on shares of Nutrien in a report on Thursday, December 12th. They set an “outperform” rating and a $60.00 target price for the company. Raymond James upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $58.00 to $60.00 in a report on Tuesday, December 3rd. CIBC restated an “outperformer” rating and set a $55.00 target price (down previously from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. Barclays restated an “equal weight” rating and set a $56.00 target price (up previously from $55.00) on shares of Nutrien in a report on Tuesday, January 21st. Finally, UBS Group increased their price target on shares of Nutrien from $51.00 to $53.00 and gave the company a “neutral” rating in a research note on Tuesday, January 28th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Nutrien currently has an average rating of “Moderate Buy” and a consensus target price of $59.00.

Read Our Latest Stock Analysis on NTR

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Earnings History for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.